DE69612755T2 - Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen - Google Patents
Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungenInfo
- Publication number
- DE69612755T2 DE69612755T2 DE69612755T DE69612755T DE69612755T2 DE 69612755 T2 DE69612755 T2 DE 69612755T2 DE 69612755 T DE69612755 T DE 69612755T DE 69612755 T DE69612755 T DE 69612755T DE 69612755 T2 DE69612755 T2 DE 69612755T2
- Authority
- DE
- Germany
- Prior art keywords
- even number
- treatment
- acids
- phenylacetate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38493595A | 1995-02-07 | 1995-02-07 | |
| PCT/US1996/000940 WO1996024571A1 (en) | 1995-02-07 | 1996-02-06 | Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69612755D1 DE69612755D1 (de) | 2001-06-13 |
| DE69612755T2 true DE69612755T2 (de) | 2001-08-23 |
Family
ID=23519346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69612755T Expired - Lifetime DE69612755T2 (de) | 1995-02-07 | 1996-02-06 | Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US5968979A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0858441B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE201013T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU4858796A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2212047C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69612755T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2157422T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR16C0003I2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1996024571A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642543B1 (en) | 2000-09-26 | 2003-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip |
| US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US6495719B2 (en) * | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
| US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US7312247B2 (en) * | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US20030195255A1 (en) * | 2002-04-12 | 2003-10-16 | Summar Marshall L. | Method for treating hepatic encephalopathies |
| US20040229948A1 (en) * | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
| EP1511477A4 (en) | 2002-05-22 | 2008-04-09 | Errant Gene Therapeutics Llc | HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS |
| JP2006508986A (ja) * | 2002-11-20 | 2006-03-16 | エルラント ゲネ セラペウチクス エルエルシー | ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法 |
| US20090260743A1 (en) * | 2003-11-21 | 2009-10-22 | William David Mawby | Tire manufacturing method for improving the uniformity of a tire |
| CA2587013A1 (en) * | 2004-11-08 | 2006-05-18 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| WO2009134460A1 (en) * | 2008-04-29 | 2009-11-05 | Hyperion Therapeutics | Methods of treatment using ammonia-scavenging drugs |
| JP5577341B2 (ja) * | 2008-08-29 | 2014-08-20 | ハイペリオン セラピューティクス, インコーポレイテッド | アンモニア捕捉薬を使用する処置方法 |
| EP3263102A1 (en) | 2011-09-30 | 2018-01-03 | Horizon Therapeutics, LLC | Methods of therapeutic monitoring of nitrogen scavenging drugs |
| BR112014026138A2 (pt) | 2012-04-20 | 2017-06-27 | Hyperion Therapeutics Inc | métodos de monitoramento terapêutico de pró-fármacos de ácido fenilacético |
| HUE036133T2 (hu) * | 2012-11-21 | 2018-06-28 | Horizon Therapeutics Llc | Eljárások hepatikus enkefalopátia kezelésére szolgáló nitrogénelvonó gyógyszerek beadására és értékelésére |
| PL2986325T3 (pl) | 2013-10-14 | 2020-03-31 | Immedica Pharma Ab | Sposoby leczenia zaburzenia cyklu mocznikowego |
| IN2013MU03442A (cg-RX-API-DMAC7.html) | 2013-10-30 | 2015-07-17 | Lupin Ltd | |
| JP2017501972A (ja) | 2013-11-14 | 2017-01-19 | ウルトラジェニクス ファーマシューティカル インク.Ultragenyx Pharmaceutical Inc. | トリグリセリドの固体組成物及びその使用 |
| EP3137116B1 (en) | 2014-04-30 | 2020-12-16 | The Johns Hopkins University | Dendrimer compositions and their use in treatment of diseases of the eye |
| EP3180031A1 (en) | 2014-08-13 | 2017-06-21 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| CN108430514B (zh) | 2015-10-29 | 2023-11-03 | 约翰霍普金斯大学 | 用于治疗过氧化物酶体病症和脑白质营养不良的组合物和方法 |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| WO2021113662A2 (en) | 2019-12-04 | 2021-06-10 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
-
1996
- 1996-02-06 WO PCT/US1996/000940 patent/WO1996024571A1/en not_active Ceased
- 1996-02-06 DE DE69612755T patent/DE69612755T2/de not_active Expired - Lifetime
- 1996-02-06 AT AT96904495T patent/ATE201013T1/de not_active IP Right Cessation
- 1996-02-06 AU AU48587/96A patent/AU4858796A/en not_active Abandoned
- 1996-02-06 ES ES96904495T patent/ES2157422T3/es not_active Expired - Lifetime
- 1996-02-06 CA CA2212047A patent/CA2212047C/en not_active Expired - Fee Related
- 1996-02-06 EP EP96904495A patent/EP0858441B1/en not_active Expired - Lifetime
-
1998
- 1998-01-13 US US09/006,432 patent/US5968979A/en not_active Expired - Lifetime
-
1999
- 1999-05-25 US US09/317,900 patent/US6083984A/en not_active Expired - Lifetime
- 1999-05-25 US US09/317,901 patent/US6060510A/en not_active Expired - Lifetime
-
2016
- 2016-02-03 FR FR16C0003C patent/FR16C0003I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0858441B1 (en) | 2001-05-09 |
| WO1996024571A1 (en) | 1996-08-15 |
| US6060510A (en) | 2000-05-09 |
| EP0858441A4 (cg-RX-API-DMAC7.html) | 1998-08-19 |
| CA2212047C (en) | 2010-11-16 |
| FR16C0003I1 (cg-RX-API-DMAC7.html) | 2016-03-25 |
| US6083984A (en) | 2000-07-04 |
| FR16C0003I2 (fr) | 2016-06-24 |
| AU4858796A (en) | 1996-08-27 |
| CA2212047A1 (en) | 1996-08-15 |
| EP0858441A1 (en) | 1998-08-19 |
| ES2157422T3 (es) | 2001-08-16 |
| DE69612755D1 (de) | 2001-06-13 |
| US5968979A (en) | 1999-10-19 |
| ATE201013T1 (de) | 2001-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69618158T2 (de) | Pharmazeutische Zusammensetzung enthaltend ein Alkanoyl-L-Carnitin in Kombination mit einer polyungesättigten Fettsäure der Omega-3-Serie zur Verhütung und Behandlung von Störungen des Fettstoffwechsels | |
| DE69821624T2 (de) | 9-cis-RETINSÄURE FÜR ZELLVERMITTELTE IMMUNKRANKHEITEN | |
| DE69927805T2 (de) | Neue fettanaloge zur behandlung von sekundärer restenose | |
| DE60116625T2 (de) | Therapeutische kombinationen von fettsäuren | |
| CA2212047C (en) | Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders | |
| DE69621756T2 (de) | Betahydroxybuttersäure oder Acetoessigsäure oder deren Salze oder Ester zur Verwendung zur Verbesserung der Gehirnfunktion | |
| DE69328910T2 (de) | Verwendung von 9-cis-Retinsäure sowie ihre Salze und Ester, zur Behandlung von Epitheltumore | |
| DE60000133T2 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
| DE69400435T2 (de) | Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen | |
| DE3438630A1 (de) | Kombinierte fettsaeurezusammensetzung zur senkung des cholesterin- und triglycerid-blutspiegels | |
| DE69624699T2 (de) | Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes | |
| EP0241809A1 (de) | Synergistische Kombination von Amantadin und Selegilin | |
| DE69635670T2 (de) | Threitol-buttersäureester-enthaltende zusammensetzungen und ihre verwendung | |
| DE4201903B4 (de) | Pharmazeutische Verwendung von Boswelliasäuren | |
| DE69517050T2 (de) | Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie | |
| DE60132008T2 (de) | Cetylmyristat und cetylpalmitat zur behandlung von ekzemen und/oder psoriasis | |
| DE10164711A1 (de) | Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren und/oder Aminosäureanalogen zur Modulation des Glycolyse-Enzym-Komplexes, des Malat Aspartat Shuttles und/oder der Transaminasen | |
| DE69029693T2 (de) | Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz | |
| LU84892A1 (fr) | Komposition zur reduktion der sebumsekretion | |
| CH695983A5 (de) | Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates. | |
| DE69501421T2 (de) | Hematetrenome Derivat als antiarteriosklerotisches Mittel | |
| DE2813121A1 (de) | Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung | |
| DE69407684T2 (de) | Verwendung von L-Carnitine oder Acyl-L-Carnitinen und Valproat zur Behandlung von Anfallserkrankungen | |
| DE3035494A1 (de) | Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels | |
| DE69332947T2 (de) | Arzneimittel enthaltend 2-(3-benzoylphenyl)-propionsäure zur verwendung als analgetikum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R065 | Request for grant of supplementary protection certificate validly filed |
Free format text: PRODUCT NAME: GLYCEROLPHENYLBUTYRAT; AUTHORISATION NO/DATE: EU/1/15/1062 20151127 Spc suppl protection certif: 122016000008 |
|
| R067 | Examining division decision granting supplementary protection certificate |
Free format text: PRODUCT NAME: GLYCEROLPHENYLBUTYRAT; AUTHORISATION NO/DATE: EU/1/15/1062 20151127 Spc suppl protection certif: 122016000008 |
|
| R069 | Supplementary protection certificate granted |
Free format text: PRODUCT NAME: GLYCEROLPHENYLBUTYRAT; AUTHORISATION NO/DATE: EU/1/15/1062 20151127 Spc suppl protection certif: 122016000008 |